What is Ibiden Co., Ltd./ADR (IBIDF)'s fair-value range?

EvidInvest does not publish a fair-value range for Ibiden Co., Ltd./ADR (IBIDF). Financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish. The filed statements, the filing citations and the growth history are all available at https://evidinvest.com/valuation/IBIDF. Not investment advice.

How is Ibiden Co., Ltd./ADR (IBIDF)'s fair value calculated?

Ibiden Co., Ltd./ADR (IBIDF)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples (PE, EV/EBITDA, P/S, P/B) benchmarked against its industry — using data from SEC filings.

What is Ibiden Co., Ltd./ADR (IBIDF)'s PE ratio versus its industry?

EvidInvest shows Ibiden Co., Ltd./ADR (IBIDF)'s current and historical PE ratio alongside its sector and industry averages, so you can see whether the stock trades at a premium or discount to peers. Full breakdown at https://evidinvest.com/valuation/IBIDF.

Fair value · Ibiden Co., Ltd./ADR (IBIDF) · updated 2026-09-13 · from annual report FY2026

Ibiden Co., Ltd./ADR trades at $138.20. We are not reading assumptions out of that price: financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish.

Everything below is unaffected: the filed statements, the filing they came from, and IBIDF’s growth history are all as reported.

Check another stock

The filing behind these numbers

Ibiden Co., Ltd./ADR

Revenue: JPY 418.8B
Diluted EPS: JPY 215.70
Free cash flow: JPY 290.8M; operating cash flow − capital expenditure
Diluted shares: 294.8M; weighted average

annual report FY2026 · fiscal year ended 2026-03-31 · filed 2026-03-31

Trailing-twelve-month EPS also uses the quarterly 6-Ks through Q1 FY2027 (filed 2026-06-30).

Open the annual report list on sec.govCIK 1654508

Valuation tool: build your own IBIDF range

Fair Value Summary

Daily Price — IBIDF

$48.02 +67.4% (1Y)

Your range0 of 7 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

The two ranges are identical because every input sits on a preset.

We don’t tell you what IBIDF is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has IBIDF’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

N/A

Financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish.

Preset inputs — revenue-driven DCF from the latest filing

Implied by today’s price

Financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish.

Not solvable from the price — Financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish. Showing preset inputs.

This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what IBIDF has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)13.91%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $1,861M · PV terminal $1,026M · EV $2,887M · equity $106,680M

Year	Stage	FCF	Present value
1	Stage 1	$306M	$268M
2	Stage 1	$321M	$247M
3	Stage 1	$337M	$228M
4	Stage 1	$354M	$210M
5	Stage 1	$371M	$194M
6	Stage 2	$381M	$174M
7	Stage 2	$390M	$157M
8	Stage 2	$400M	$141M
9	Stage 2	$410M	$127M
10	Stage 2	$420M	$114M

Inputs from the filing

Financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish.

Free cash flow: JPY 93.5B; sum of the last four quarters
EBIT: JPY 58.5B; latest annual
Shares: 279.2M
Total debt: JPY 193.7B
Cash: JPY 297.5B
Net debt: JPY -103.8B; debt − cash

annual report FY2026 · period ended 2026-03-31 · filed 2026-03-31 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for IBIDF

Loading history...

Ibiden Co., Ltd./ADR trades at $138.20. We are not reading assumptions out of that price: financials are filed in JPY; our prices are in USD, so these methods need a conversion we do not yet publish.

The filing behind these numbers

Valuation tool: build your own IBIDF range

Daily Price — IBIDF

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on IBIDF

Compare with peers

Explore

Valuation tool: build your own IBIDF range

Daily Price — IBIDF

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on IBIDF

Compare with peers

Explore